RetinalGenix Technologies (RTGN) Profit After Tax (QoQ) (2021 - 2026)
RetinalGenix Technologies (RTGN) Profit After Tax (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24% |
| Dec 31, 2025 | -9.55% |
| Sep 30, 2025 | 12.42% |
| Jun 30, 2025 | -10.58% |
| Mar 31, 2025 | 32.27% |
| Dec 31, 2024 | -34.57% |
| Sep 30, 2024 | 2.91% |
| Jun 30, 2024 | 69.07% |
| Mar 31, 2024 | -296.18% |
| Dec 31, 2023 | 21.10% |
| Sep 30, 2023 | -94.94% |
| Jun 30, 2023 | 31.04% |
| Mar 31, 2023 | 24.34% |
| Dec 31, 2022 | 73.05% |
| Sep 30, 2022 | -596.98% |
| Jun 30, 2022 | 4.23% |
| Mar 31, 2022 | 8.43% |
| Dec 31, 2021 | 25.64% |
| Sep 30, 2021 | -3.02% |
| Jun 30, 2021 | 21.77% |